These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19716866)

  • 1. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
    Brouillet F; Baylac G; Cartilier L; Bataille B
    Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxylated high amylose starch as pharmaceutical excipients. Structural insights and formulation of pancreatic enzymes.
    Massicotte LP; Baille WE; Mateescu MA
    Int J Pharm; 2008 May; 356(1-2):212-23. PubMed ID: 18403141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations.
    Calinescu C; Mulhbacher J; Nadeau E; Fairbrother JM; Mateescu MA
    Eur J Pharm Biopharm; 2005 May; 60(1):53-60. PubMed ID: 15848056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation.
    Calinescu C; Nadeau E; Mulhbacher J; Fairbrother JM; Mateescu MA
    Int J Pharm; 2007 Oct; 343(1-2):18-25. PubMed ID: 17537598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR imaging of chitosan and carboxymethyl starch tablets: swelling and hydration of the polyelectrolyte complex.
    Wang YJ; Assaad E; Ispas-Szabo P; Mateescu MA; Zhu XX
    Int J Pharm; 2011 Oct; 419(1-2):215-21. PubMed ID: 21864660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO; Wang YJ
    Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
    Lemieux M; Gosselin P; Mateescu MA
    AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.